ArticleJournal of the American Society for Mass Spectrometry2023
Simple Tool for Rapidly Assessing the Quality of Multiplexed Single Cell Proteomics Data.
Article in Journal of the American Society for Mass Spectrometry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Spatial proteomics in precision medicine: technologies, bioinformatics, and translational applications.Precision clinical medicine · 2026Review
- Simultaneous single-cell proteomics and epigenetic analysis of histone deacetylase inhibition in human cells.Communications biology · 2025Article
- Trends in Mass Spectrometry-Based Single-Cell Proteomics.Analytical chemistry · 2025Review
- Quality Control in the Mass Spectrometry Proteomics Core: A Practical Primer.Journal of biomolecular techniques : JBT · 2024Article
- Single cell proteomics by mass spectrometry reveals deep epigenetic insight into the actions of an orphan histone deacetylase inhibitor.bioRxiv : the preprint server for biology · 2024Article
- Pushing the Isotopic Envelope: When carrier channels pollute their neighbors' signals.bioRxiv : the preprint server for biology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Recent advances in the sensitivity and speed of mass spectrometers coupled with improved sample preparation methods have enabled the field of single cell proteomics to proliferate. While heavy development is occurring in the label free space, dramatic improvements in throughput are provided by multiplexing with tandem mass tags. Hundreds or thousands of single cells can be analyzed with this method, yielding large data sets which may contain poor data arising from loss of material during cell sorting or poor digestion, labeling, and lysis. To date, no tools have been described that can assess data quality prior to data processing. We present herein a lightweight python script and accompanying graphic user interface that can rapidly quantify reporter ion peaks within each MS/MS spectrum in a file. With simple summary reports, we can identify single cell samples that fail to pass a set quality threshold, thus reducing analysis time waste. In addition, this tool, Diagnostic Ion Data Analysis Reduction (DIDAR), will create reduced MGF files containing only spectra possessing a user-specified number of single cell reporter ions. By reducing the number of spectra that have excessive zero values, we can speed up sample processing with little loss in data completeness as these spectra are removed in later stages in data processing workflows. DIDAR and the DIDAR GUI are compatible with all modern operating systems and are available at: https://github.com/orsburn/DIDARSCPQC. All files described in this study are available at www.massive.ucsd.edu as accession MSV000088887.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.